|
US5075447A
(en)
|
1984-09-17 |
1991-12-24 |
Hoffmann-La Roche Inc. |
Ruthenium complexes useful as carriers for immunologically active materials
|
|
DK365785A
(da)
|
1984-09-17 |
1986-03-18 |
Hoffmann La Roche |
Metalcomplexer
|
|
GB8601646D0
(en)
|
1986-01-23 |
1986-02-26 |
Davidson R S |
Binding assay & reagent
|
|
US5585279A
(en)
|
1986-01-23 |
1996-12-17 |
Davidson; Robert S. |
Time-resolved luminescence binding assays using a fluorescent transition metal label other than ruthenium
|
|
US6018030A
(en)
|
1986-11-04 |
2000-01-25 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
|
ES2093090T3
(es)
|
1989-12-28 |
1996-12-16 |
Upjohn Co |
Compuestos sustituidos diaromaticos anti-sida.
|
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
WO1996013510A1
(en)
|
1994-10-28 |
1996-05-09 |
Procept, Inc. |
Ruthenium complexes and their use as immunosuppressive agents
|
|
US5708022A
(en)
|
1994-10-28 |
1998-01-13 |
Procept, Inc. |
Method for inhibiting immune response
|
|
US5712127A
(en)
|
1996-04-29 |
1998-01-27 |
Genescape Inc. |
Subtractive amplification
|
|
US5831003A
(en)
|
1996-06-28 |
1998-11-03 |
Bayer Corporation |
Peptides which bind to prothrombin and thrombin
|
|
EP0991777A1
(en)
|
1997-06-18 |
2000-04-12 |
Ulrich J. Krull |
Nucleic acid biosensor diagnostics
|
|
AU1824899A
(en)
|
1997-12-15 |
1999-07-05 |
Joseph R Lakowicz |
Method and composition for characterizing a sample containing a sample lipid andan assay kit
|
|
US6759243B2
(en)
|
1998-01-20 |
2004-07-06 |
Board Of Trustees Of The University Of Illinois |
High affinity TCR proteins and methods
|
|
US6472367B1
(en)
|
1998-05-05 |
2002-10-29 |
Adherex Technologies, Inc. |
Compounds and methods for modulating OB-cadherin mediated cell adhesion
|
|
ATE380865T1
(de)
|
1998-05-13 |
2007-12-15 |
Domantis Ltd |
Phagen-display-selektionssystem für korrekt gefaltete proteine
|
|
WO1999058546A1
(en)
*
|
1998-05-13 |
1999-11-18 |
Ludwig Institute For Cancer Research |
Tumor associated antigen encoded by the reverse strand of a new ubiquitously expressed gene
|
|
US7037667B1
(en)
|
1998-06-01 |
2006-05-02 |
Agensys, Inc. |
Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
|
|
US7521197B2
(en)
|
1998-06-05 |
2009-04-21 |
Alexis Biotech Limited |
Method for producing cytotoxic T-cells
|
|
US20020106678A1
(en)
*
|
1998-06-30 |
2002-08-08 |
Robishaw Janet D. |
cDNA clones encoding human G protein gamma subunits
|
|
JP2002519428A
(ja)
|
1998-07-02 |
2002-07-02 |
メルク エンド カムパニー インコーポレーテッド |
プレニル−タンパク質トランスフェラーゼの阻害剤
|
|
US6288221B1
(en)
|
1998-08-20 |
2001-09-11 |
Duke University |
Methods of synthesis of halogen base-modified oligonucleotides and subsequent labeling with a metal-catalyzed reaction
|
|
WO2000014515A1
(en)
|
1998-09-08 |
2000-03-16 |
University Of Maryland At Baltimore |
Low frequency modulation sensors using nanosecond fluorophores
|
|
US6806089B1
(en)
|
1998-09-08 |
2004-10-19 |
University Of Maryland, Baltimore |
Low frequency modulation sensors using nanosecond fluorophores
|
|
AU1223400A
(en)
|
1998-10-22 |
2000-05-08 |
Phillip B. B. Moheno |
Novel pterin antineoplastic agents
|
|
IL145290A0
(en)
|
1999-03-19 |
2002-06-30 |
Anormed Inc |
Pharmaceutical compositions comprising complexes
|
|
US6872519B1
(en)
|
1999-04-27 |
2005-03-29 |
Mirus Bio Corporation |
In vitro process for selecting phage resistant to blood inactivation
|
|
US20090087878A9
(en)
|
1999-05-06 |
2009-04-02 |
La Rosa Thomas J |
Nucleic acid molecules associated with plants
|
|
US20030024579A1
(en)
|
1999-07-07 |
2003-02-06 |
Blackmore Donald Ian |
Diverter valve
|
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
|
NZ517828A
(en)
|
1999-09-17 |
2003-10-31 |
Millennium Pharm Inc |
Inhibitors having activity against mammalian factor Xa
|
|
WO2001046209A1
(en)
|
1999-12-20 |
2001-06-28 |
Fluorrx, Inc. |
Fluorescent probes
|
|
US20030219806A1
(en)
|
2000-02-22 |
2003-11-27 |
Millennium Pharmaceuticals, Inc. |
Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor
|
|
US7585839B2
(en)
|
2000-02-23 |
2009-09-08 |
Zealand Pharma A/S |
Medical uses of intercellular communication facilitating compounds
|
|
US20030215860A1
(en)
|
2000-02-29 |
2003-11-20 |
Millennium Pharmaceuticals, Inc. |
Novel 18636, 2466, 43238, 1983, 52881, 2398, 45449, 50289, 52872 and 26908 molecules and uses therefor
|
|
AU4592601A
(en)
*
|
2000-03-21 |
2001-10-03 |
Millennium Predictive Medicine |
Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer
|
|
US6436703B1
(en)
|
2000-03-31 |
2002-08-20 |
Hyseq, Inc. |
Nucleic acids and polypeptides
|
|
US7834146B2
(en)
|
2000-05-08 |
2010-11-16 |
Monsanto Technology Llc |
Recombinant polypeptides associated with plants
|
|
AU2001269836A1
(en)
*
|
2000-06-16 |
2002-01-02 |
Incyte Genomics, Inc. |
Proteases
|
|
WO2002006339A2
(en)
|
2000-07-03 |
2002-01-24 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
|
US20050053930A1
(en)
|
2000-07-18 |
2005-03-10 |
David Anderson |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
US6812339B1
(en)
|
2000-09-08 |
2004-11-02 |
Applera Corporation |
Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
|
|
GB0023008D0
(en)
|
2000-09-20 |
2000-11-01 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
US7320793B2
(en)
|
2001-01-19 |
2008-01-22 |
Cytos Biotechnology Ag |
Molecular antigen array
|
|
TW200526779A
(en)
|
2001-02-08 |
2005-08-16 |
Wyeth Corp |
Modified and stabilized GDF propeptides and uses thereof
|
|
US6783969B1
(en)
*
|
2001-03-05 |
2004-08-31 |
Nuvelo, Inc. |
Cathepsin V-like polypeptides
|
|
US7030236B2
(en)
|
2001-03-09 |
2006-04-18 |
Mona Savitri Jhaveri |
Antisense oligonucleotides tarageting folate receptor alpha, and the use thereof
|
|
US20030087250A1
(en)
|
2001-03-14 |
2003-05-08 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
|
US20030065157A1
(en)
*
|
2001-04-04 |
2003-04-03 |
Lasek Amy W. |
Genes expressed in lung cancer
|
|
US7736654B2
(en)
|
2001-04-10 |
2010-06-15 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
AU2002309583A1
(en)
*
|
2001-04-18 |
2002-11-05 |
Protein Desing Labs, Inc. |
Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
|
|
JP2005508144A
(ja)
*
|
2001-06-18 |
2005-03-31 |
イオス バイオテクノロジー，インコーポレイティド |
卵巣癌の診断方法、卵巣癌のモジュレーターをスクリーニングする組成物及び方法
|
|
US20040053824A1
(en)
|
2001-06-29 |
2004-03-18 |
Tang Y Tom |
Extracellular matrix and cell adhesion molecules
|
|
US20030099974A1
(en)
*
|
2001-07-18 |
2003-05-29 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kits and methods for identification, assessment, prevention, and therapy of breast cancer
|
|
EP1420809B1
(en)
|
2001-08-31 |
2011-09-28 |
BTG International Limited |
Use of cyclopenta[g]quinazoline derivatives for treating cancer
|
|
JP4328202B2
(ja)
|
2001-08-31 |
2009-09-09 |
ビーティージー・インターナショナル・リミテッド |
抗癌シクロペンタ［ｇ］キナゾリン化合物
|
|
US7622260B2
(en)
|
2001-09-05 |
2009-11-24 |
The Brigham And Women's Hospital, Inc. |
Diagnostic and prognostic tests
|
|
US20030124579A1
(en)
|
2001-09-05 |
2003-07-03 |
Eos Biotechnology, Inc. |
Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
|
|
AR045702A1
(es)
|
2001-10-03 |
2005-11-09 |
Chiron Corp |
Composiciones de adyuvantes.
|
|
NZ533158A
(en)
|
2001-11-19 |
2006-09-29 |
Elan Pharm Inc |
3,4-Disubstituted, 3,5-disubstituted and 3,4,5-substituted piperidines and piperazines
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
JP2005525096A
(ja)
|
2002-01-09 |
2005-08-25 |
ユニバーシティ オブ ローザンヌ |
Ｊｎｋシグナル伝達経路の細胞浸透性ペプチドインヒビター
|
|
ATE371680T1
(de)
|
2002-01-16 |
2007-09-15 |
Biocompatibles Uk Ltd |
Polymerkonjugate
|
|
CA2474723A1
(en)
|
2002-01-28 |
2003-08-07 |
Keraplast Technologies, Ltd. |
Bioactive keratin peptides
|
|
US6962910B2
(en)
|
2002-02-01 |
2005-11-08 |
Virginia Tech Intellectual Properties, Inc. |
Supramolecular complexes as photoactivated DNA cleavage agents
|
|
AU2003225573A1
(en)
*
|
2002-02-13 |
2003-09-04 |
The Government Of The United States Of America As Represented By The Secretary, Department Of He |
Identification of ovarian cancer tumor markers and therapeutic targets
|
|
DE10206616A1
(de)
|
2002-02-15 |
2003-09-04 |
Qiagen Gmbh |
Verfahren zur Reduktion der Background-Kontamination nach Markierungsreaktionen
|
|
EP1490101A4
(en)
|
2002-03-05 |
2006-09-20 |
Univ Texas |
METHODS OF IMPROVING INDUCTION OF IMMUNE RESPONSE INVOLVING MDA-7
|
|
US20040101874A1
(en)
|
2002-04-12 |
2004-05-27 |
Mitokor Inc. |
Targets for therapeutic intervention identified in the mitochondrial proteome
|
|
PL375064A1
(en)
*
|
2002-05-20 |
2005-11-14 |
Abgenix, Inc. |
Treatment of renal carcinoma using antibodies against the egfr
|
|
AU2003295328A1
(en)
*
|
2002-10-02 |
2004-04-23 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
EP1422242A1
(en)
|
2002-11-22 |
2004-05-26 |
Emory University |
Plastic and elastic protein copolymers
|
|
KR20050115231A
(ko)
*
|
2003-02-10 |
2005-12-07 |
내셔날 인스티튜트 오브 어드밴스드 인더스트리얼 사이언스 앤드 테크놀로지 |
포유동물 세포의 조절
|
|
WO2004087874A2
(en)
|
2003-03-28 |
2004-10-14 |
Nuvelo, Inc. |
Novel nucleic acids and polypeptides
|
|
AU2004240765B2
(en)
|
2003-05-20 |
2009-03-19 |
Cellpep Sa |
Modified antiviral peptides with increased activity and cell membrane affinity
|
|
WO2004104197A1
(en)
*
|
2003-05-21 |
2004-12-02 |
Genesense Technologies Inc. |
Antisense oligonucleotides directed to ribonucleotide reductase r1 and uses thereof in the treatment of cancer
|
|
US20060078941A1
(en)
|
2003-06-09 |
2006-04-13 |
Santin Alessandro D |
Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium
|
|
WO2006003352A1
(en)
|
2004-07-06 |
2006-01-12 |
Warwick Effect Polymers Limited |
Living radical polymerization initiator comprising a functional group capable of reacting with polyeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom
|
|
GB0314472D0
(en)
|
2003-06-20 |
2003-07-23 |
Warwick Effect Polymers Ltd |
Polymer
|
|
GB0318096D0
(en)
|
2003-08-01 |
2003-09-03 |
Queen Mary & Westfield College |
Vaccine
|
|
DE10335833A1
(de)
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
|
US20070178458A1
(en)
|
2003-09-05 |
2007-08-02 |
O'brien Philippa |
Methods of diagnosis and prognosis of ovarian cancer II
|
|
US20050147621A1
(en)
|
2003-10-10 |
2005-07-07 |
Higgins Darren E. |
Use of bacterial 5' untranslated regions for nucleic acid expression
|
|
DE10347710B4
(de)
|
2003-10-14 |
2006-03-30 |
Johannes-Gutenberg-Universität Mainz |
Rekombinante Impfstoffe und deren Verwendung
|
|
WO2005039504A2
(en)
|
2003-10-24 |
2005-05-06 |
Eisai Co., Ltd. |
Compounds and methods for treating toll-like receptor 2-related diseases and conditions
|
|
US20050153333A1
(en)
|
2003-12-02 |
2005-07-14 |
Sooknanan Roy R. |
Selective terminal tagging of nucleic acids
|
|
EP1550458A1
(en)
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
|
EP1547581A1
(en)
|
2003-12-23 |
2005-06-29 |
Vectron Therapeutics AG |
Liposomal vaccine for the treatment of human hematological malignancies
|
|
WO2005066337A2
(en)
|
2004-01-09 |
2005-07-21 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation
|
|
WO2005076979A2
(en)
|
2004-02-06 |
2005-08-25 |
Wyeth |
Diagnosis and therapeutics for cancer
|
|
US7666583B2
(en)
|
2004-02-19 |
2010-02-23 |
Yale University |
Identification of cancer protein biomarkers using proteomic techniques
|
|
AU2005215943A1
(en)
|
2004-03-01 |
2005-09-09 |
Peptera Pharmaceutical Ltd. |
Casein derived peptides and therapeutic uses thereof
|
|
WO2007084413A2
(en)
|
2004-07-14 |
2007-07-26 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis c
|
|
US7772271B2
(en)
|
2004-07-14 |
2010-08-10 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
|
US7553944B2
(en)
|
2004-07-21 |
2009-06-30 |
The University Of Hong Kong |
Human virus causing respiratory tract infection and uses thereof
|
|
WO2006026569A2
(en)
|
2004-08-27 |
2006-03-09 |
Northeastern University |
Comprehensive characterization of complex proteins at trace levels
|
|
DE102004042546A1
(de)
|
2004-09-02 |
2006-03-09 |
Curevac Gmbh |
Kombinationstherapie zur Immunstimulation
|
|
WO2006027202A1
(en)
|
2004-09-06 |
2006-03-16 |
Unite De Recherche En Biotherapie Et Oncologie (Rubio) |
Generation of multiparent cell hybrids
|
|
AU2005282241B2
(en)
|
2004-09-08 |
2011-03-03 |
Chelsea Therapeutics, Inc. |
Quinazoline derivatives as metabolically inert antifolate compounds.
|
|
US8247371B2
(en)
|
2004-10-14 |
2012-08-21 |
Yale University |
Therapy with Clostridium perfringens enterotoxin to treat ovarian and uterine cancer
|
|
HUE026826T2
(en)
|
2004-10-29 |
2016-07-28 |
Ratiopharm Gmbh |
Modeling and glycopegylation of fibroblast growth factor (FGF)
|
|
US7429567B2
(en)
|
2005-01-04 |
2008-09-30 |
The Brigham And Women's Hospital, Inc. |
Sustained delivery of PDGF using self-assembling peptide nanofibers
|
|
CN101133037B
(zh)
|
2005-01-27 |
2012-05-09 |
旭化成制药株式会社 |
六元杂环化合物及其用途
|
|
US7531533B2
(en)
|
2005-01-27 |
2009-05-12 |
Asahi Kasei Pharma Corporation |
6-Membered heterocyclic compound and use thereof
|
|
BRPI0607323B8
(pt)
|
2005-02-14 |
2021-05-25 |
Epitopix Llc |
composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo
|
|
KR20080003321A
(ko)
|
2005-02-24 |
2008-01-07 |
세미네스 인코퍼레이티드 |
생물학적 샘플을 분류하는 조성물 및 방법
|
|
WO2006102097A2
(en)
|
2005-03-17 |
2006-09-28 |
President And Fellows Of Harvard College |
Synthesis of avrainvillamide, stephacidin b, and analogues thereof
|
|
FR2885525B1
(fr)
|
2005-05-13 |
2009-09-18 |
Urodelia Sa |
Medicament notamment anti-cancereux, destine a des traitements par immunotherapie, en particulier autologue
|
|
WO2006138238A2
(en)
|
2005-06-13 |
2006-12-28 |
Cleveland Biolabs, Inc. |
Methods of protecting against apoptosis using lipopeptides
|
|
WO2006138380A2
(en)
|
2005-06-15 |
2006-12-28 |
Massachusetts Institute Of Technology |
Amine-containing lipids and uses thereof
|
|
MX2008000141A
(es)
|
2005-06-27 |
2008-04-07 |
Exelixis Inc |
Moduladores de lxr basados en imidazol.
|
|
WO2007005249A2
(en)
|
2005-06-29 |
2007-01-11 |
Hyperbranch Medical Technology, Inc. |
Nanoparticles and dendritic-polymer-based hydrogels comprising them
|
|
US7494788B2
(en)
|
2005-07-11 |
2009-02-24 |
Molecular Kinetics, Inc. |
Entropic bristle domain sequences and their use in recombinant protein production
|
|
US7820790B2
(en)
|
2005-07-13 |
2010-10-26 |
Amgen Mountain View Inc. |
IL-6 binding proteins
|
|
GB0516058D0
(en)
|
2005-08-04 |
2005-09-14 |
Oxford Genome Sciences Uk Ltd |
New protein isoforms and uses thereof
|
|
GB0517293D0
(en)
|
2005-08-24 |
2005-10-05 |
Cancer Rec Tech Ltd |
Vectors and uses thereof
|
|
DE602006014846D1
(de)
|
2005-09-15 |
2010-07-22 |
Alk Abello As |
Verfahren zur quantifizierung von allergenen
|
|
WO2007044804A2
(en)
|
2005-10-11 |
2007-04-19 |
Chemocentryx, Inc. |
Piperidine derivatives and methods of use
|
|
AU2006303037A1
(en)
|
2005-10-21 |
2007-04-26 |
Merz Pharma Gmbh & Co Kgaa |
Chromenones and their use as modulators of metabotropic glutamate receptors
|
|
UA96139C2
(uk)
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
|
ATE486875T1
(de)
|
2005-11-10 |
2010-11-15 |
Chemocentryx Inc |
Substituierte chinolone und verwendungsverfahren
|
|
EP1954134B1
(en)
|
2005-11-23 |
2011-09-14 |
Merck Sharp & Dohme Corp. |
Process for synthesizing a 2-phenyl-1h-phenantrho[9,10-d]imidazole derivative
|
|
KR101049859B1
(ko)
|
2007-11-28 |
2011-07-19 |
대한민국 |
Ｎ-말단 ｐＩ 값 조절에 의한 수용성 재조합 단백질 생산방법
|
|
KR20080113223A
(ko)
|
2006-03-06 |
2008-12-29 |
심포젠 에이/에스 |
호흡기세포 융합 바이러스 감염 치료용 재조합 폴리클로날 항체
|
|
JP5167155B2
(ja)
|
2006-03-09 |
2013-03-21 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
ペプチド結合に基づく多数の細胞株のプロファイリングに関連した組成物および方法
|
|
EP1996629A2
(en)
|
2006-03-10 |
2008-12-03 |
Warwick Effect Polymers Ltd. |
Polymers
|
|
WO2007110755A1
(en)
|
2006-03-27 |
2007-10-04 |
Medical Therapies Limited |
Prophylaxis or treatment of cardiovascular inflammation
|
|
CA2649800C
(en)
|
2006-04-20 |
2016-09-20 |
Kringle Pharma Inc. |
Hgf precursor protein variant and active protein thereof
|
|
US20090253156A1
(en)
|
2006-05-05 |
2009-10-08 |
Perkinelmer Las, Inc. |
Mass spectrometry methods for multiplexed quantification of protein kinases and phosphatases
|
|
EP2021467A4
(en)
|
2006-05-08 |
2010-01-20 |
Adaerata Ltd Partnership |
CHIMERIC PCSK9 PROTEINS, THESE INCLUDING CELLS AND TEST METHODS THEREWITH
|
|
EP2502628B1
(en)
*
|
2006-06-23 |
2016-12-14 |
Alethia Biotherapeutics Inc. |
Polynucleotides and polypeptide sequences involved in cancer
|
|
NL1032064C2
(nl)
*
|
2006-06-27 |
2008-01-02 |
Walraven Holding Bv J Van |
Pijpbeugel met trillingisolerende inlaag.
|
|
EP2041556A1
(en)
|
2006-06-28 |
2009-04-01 |
RGB Technologies AB |
A sensor kit and a system for detecting an analyte in a test environment
|
|
US8198046B2
(en)
|
2006-07-11 |
2012-06-12 |
Danisco Us Inc. |
KEX2 cleavage regions of recombinant fusion proteins
|
|
US20080248959A1
(en)
|
2006-07-21 |
2008-10-09 |
Neose Technologies, Inc. |
Glycosylation of peptides via o-linked glycosylation sequences
|
|
EP2121747A2
(en)
|
2006-07-27 |
2009-11-25 |
Oxford Genome Sciences (UK) Limited |
New protein isoforms and uses thereof
|
|
US20100120627A1
(en)
*
|
2006-08-02 |
2010-05-13 |
Abdelmajid Belouchi |
Genemap of the human genes associated with psoriasis
|
|
JP5244103B2
(ja)
|
2006-08-09 |
2013-07-24 |
ホームステッド クリニカル コーポレイション |
器官特異的蛋白質およびその使用方法
|
|
US8314221B2
(en)
|
2006-09-07 |
2012-11-20 |
Laurence Claude Faure |
Pharmacodiagnostic test targeting oncology and neurodegeneration
|
|
WO2008033932A2
(en)
|
2006-09-13 |
2008-03-20 |
The Institutes For Pharmaceutical Discovery, Llc |
Biarylthiazole carboxylic acid derivatives as protein tyrosine phosphatase-ib inhibitors
|
|
CN101663308A
(zh)
|
2006-10-30 |
2010-03-03 |
桑尔克斯药品公司 |
N-甲基色胺钙五水合物(dcp)和基于它的治疗方法
|
|
DE102006051516A1
(de)
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
|
CA2672860C
(en)
|
2006-12-28 |
2013-01-29 |
Abbott Laboratories |
Inhibitors of poly(adp-ribose)polymerase
|
|
KR101493474B1
(ko)
|
2007-01-09 |
2015-02-16 |
클리브랜드 바이오랩스, 아이엔씨. |
조혈 줄기 세포를 증가시키고 이동시키는 방법들
|
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
|
US20080311145A1
(en)
|
2007-04-04 |
2008-12-18 |
Specigen, Inc. |
Protein cage immunotherapeutics
|
|
WO2008134761A2
(en)
|
2007-04-30 |
2008-11-06 |
Intezyne Technologies, Inc. |
Modification of biological targeting groups for the treatment of cancer
|
|
US20080306007A1
(en)
|
2007-04-30 |
2008-12-11 |
Newcastle Innovation Limited |
Agents for prophylaxis or treatment of neurological related diseases and conditions
|
|
US8143372B2
(en)
|
2007-05-21 |
2012-03-27 |
Children's Hospital & Research Center Oakland |
Synthetic regulators of ferritin protein nanocage pores and methods of use thereof
|
|
US20090176664A1
(en)
|
2007-06-01 |
2009-07-09 |
Keting Chu |
High density peptide arrays containing kinase or phosphatase substrates
|
|
US8618121B2
(en)
|
2007-07-02 |
2013-12-31 |
Cancer Research Technology Limited |
9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors
|
|
US9018138B2
(en)
|
2007-08-16 |
2015-04-28 |
The Johns Hopkins University |
Compositions and methods for generating and screening adenoviral libraries
|
|
CN101821289A
(zh)
|
2007-09-07 |
2010-09-01 |
西福根有限公司 |
重组制造抗rsv抗体的方法
|
|
GB0719644D0
(en)
|
2007-10-05 |
2007-11-14 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
US20100298368A1
(en)
|
2007-11-06 |
2010-11-25 |
Amira Pharmaceuticals, Inc. |
Antagonists of pgd2 receptors
|
|
WO2009111088A2
(en)
|
2008-01-02 |
2009-09-11 |
The Johns Hopkins University |
Antitumor immunization by liposomal delivery of vaccine to the spleen
|
|
US8568709B2
(en)
|
2008-03-20 |
2013-10-29 |
University Health Network |
Thymidylate kinase fusions and uses thereof
|
|
JP5777510B2
(ja)
|
2008-05-09 |
2015-09-09 |
エボニック コーポレイションＥｖｏｎｉｋ Ｃｏｒｐｏｒａｔｉｏｎ |
生物適合性及び生分解性のエラストマー性ポリマー
|
|
US20110123637A1
(en)
|
2008-05-26 |
2011-05-26 |
Universitat Zurich |
Protamine/rna nanoparticles for immunostimulation
|
|
PE20100094A1
(es)
|
2008-07-03 |
2010-02-18 |
Amira Pharmaceuticals Inc |
Antagonistas heteroalquilo de receptores de prostaglandina d2
|
|
US8148088B2
(en)
|
2008-07-18 |
2012-04-03 |
Abgent |
Regulation of autophagy pathway phosphorylation and uses thereof
|
|
WO2010014141A1
(en)
|
2008-08-01 |
2010-02-04 |
Lixte Biotechnology, Inc. |
Methods for regulating cell mitosis by inhibiting serine/threonine phosphatase
|
|
ES2415234T3
(es)
|
2008-08-08 |
2013-07-24 |
Synta Pharmaceuticals Corp. |
Compuestos de triazol que modulan la actividad Hsp90
|
|
MX2011003117A
(es)
|
2008-09-19 |
2011-04-21 |
Nektar Therapeutics |
Conjugados polimericos de peptidos terapeuticos.
|
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
|
WO2010060186A1
(en)
|
2008-11-03 |
2010-06-03 |
Alethia Biotherapeutics Inc. |
Antibodies that specifically block the biological activity of a tumor antigen
|
|
WO2011054112A1
(en)
|
2009-11-03 |
2011-05-12 |
Alethia Biotherapeutics Inc. |
Antibodies that specifically block the biological activity of kidney associated antigen 1
|